Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic Study to Assess and Compare the Drug Interaction Risk of the Grapefruit Juice and Dietary Supplements Known to Inhibit CYP3A Enzyme Activity

NCT02257879 is registered in ClinicalTrials.gov with National Institute of Environmental Health Sciences (NIEHS) as lead sponsor.

NCT NCT02257879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02257879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic Study to Assess and Compare the Drug Interaction Risk of the Grapefruit Juice and Dietary Supplements Known to Inhibit CYP3A Enzyme Activity
Lead sponsor
National Institute of Environmental Health Sciences (NIEHS)
Phase
Observational
Overall status
Withdrawn
Start date
October 3, 2014
Completion date
April 20, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers